4
Changes in Ownership
Altimmune, Inc. Filed Acc 0001705905-26-000006
Chief Scientific Officer gave up 5,188 shares (to pay taxes)
- Chief Scientific Officer acquired 5,567 shares (grant or award)
- Chief Scientific Officer acquired 17,050 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Roberts M Scot · Chief Scientific Officer
Table I: Non-derivative
5 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-30 | Exercise or conversion : show line 1 in the form | +9,275 | 104,670 | D | ||
| 2026-01-30 | Shares withheld for taxes : show line 2 in the form | −2,859 | $5.60 | $16,010 | 101,811 | D |
| 2026-01-31 | Grant or award : show line 3 in the form | +5,567 | $3.07 | $17,091 | 107,378 | D |
| 2026-02-02 | Exercise or conversion : show line 4 in the form | +7,775 | 115,153 | D | ||
| 2026-02-02 | Shares withheld for taxes : show line 5 in the form | −2,329 | $5.55 | $12,926 | 112,824 | D |
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-30 | Exercise or conversion : show line 6 in the form Restricted Stock Units | −9,275 | 9,275 | D |
| 2026-02-02 | Exercise or conversion : show line 7 in the form Restricted Stock Units | −7,775 | 0 | D |
Loading xslF345X05/form4-02032026_040235.xml…